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The envelope glycoproteins of Semliki Forest virus (SFV), 
Vesicular Stomatitis virus (VSV), and Influenza Fowl Plague 
virus (FPV) are vectorially targeted in neurons to the plas- 
ma membrane of dendrites (SFV and VSV) and axons 
(FPV). To gain insight into the mechanisms responsible for 
such polarized delivery we have examined the effects on 
neurons of nocodazole and brefeldin A (BFA), which are 
known to cause microtubule depolymerization and disas- 
sembly of the Golgi apparatus, respectively. Nocodazole 
treatment blocked transport of all viral glycoproteins to 
both axons and dendrites. BFA treatment induced disrup- 
tion of the Golgi complex, including the trans-Golgi net- 
work (TGN), and tubulation of endosomes. However, the 
delivery of the SFV and FPV glycoproteins to the cell sur- 
face was not affected significantly by BFA, although pro- 
cessing and sorting were altered, as revealed by surface 
biotinylation and immunofluorescence microscopy of fixed 
nonpermeabilized cells. These results demonstrate the in- 
volvement of microtubules in axonal and dendritic trans- 
port of integral membrane glycoproteins, and the existence 
of a BFA-sensitive component in the sorting but not in the 
transport machinery. 
[Key words: microtubules, sorting, virus, hippocampus, 
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Neurons are characterized by a.polarized cell surface organiza- 
tion that segregates and maintains proteins into two discrete 
functional domains: the axonal and the somatodendritic plasma 
membrane. This molecular segregation is essential for the effi- 
ciency of the vectorial functions of nerve cells. In previous work 
on the mechanisms governing protein sorting in neurons (Dotti 
and Simons, 1990; Kobayashi et al., 1992; Dotti et al., 1993), 
we have applied experimental strategies such as infection with 
enveloped viruses that have proven useful to study the mecha- 
nisms of sorting of apical and basolateral proteins in epithelial 
cells. In these cells, the influenza virus hemagglutinin (HA) is 
routed to the apical surface while the spike glycoproteins of 
VSV and SFV are delivered to the basolateral surface (Rodri- 
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guez-Boulan and Pendergast, 1980; Fuller et al., 1985; Roman 
and Garoff, 1986). When sorting of these viral glycoproteins was 
studied in hippocampal cells cultured from l&d-old rat embry- 
os, a well-established neuronal culture system (Goslin and Bank- 
er, 1991), we found that the influenza HA was routed to the 
axon while the VSV and SFV glycoproteins were distributed to 
the somatodendritic cell surface (Dotti and Simons, 1990; Dotti 
et al., 1993). These observations suggested that, at least in the 
way viral glycoproteins are sorted, the axonal and dendritic do- 
mains of neurons are equivalent to the apical and basolateral 
domains of epithelial cells, respectively. 
Microtubules have been shown to be involved in protein de- 
livery to the apical surface in epithelial cells (Rindler et al., 
1987; Breitfeld et al., 1990; Gilbert et al, 1991) as well as in 
axonal transport in neurons (Kelly, 1990). However, it is likely 
that different motors drive apical and axonal delivery, since mi- 
crotubules are oriented in opposite ways in the two cell types: 
with their minus ends toward the apical membrane in epithelial 
cells (Bacallao et al., 1989) and toward the cell body in neurons 
(Baas et al., 1988). In epithelial cells, microtubules seem not to 
be required for basolateral delivery of viral glycoproteins (Salas 
et al., 1986; Rindler et al., 1987), although in an in vitro assay 
both apical and basolateral vesicles bound specifically to micro- 
tubules (van der Sluijs et al., 1990). In neurons, intact micro- 
tubules are required for membrane transport in the axons (re- 
viewed in Hammerschlag and Brady, 1988; Brady et al., 199). 
Little is known, however, about the requirement for microtubules 
in dendritic transport of exocytic vesicles. 
In this work, we have extended the analysis of the mecha- 
nisms of protein targeting to the surface of polarized hippocam- 
pal neurons in culture. To this end we used viral glycoproteins 
as markers for either axonal or somatodendritic sorting, and have 
studied the effects on their transport to the cell surface of two 
different inhibitors of intracellular membrane traffic: nocodazo- 
le, a microtubule depolymerizing agent; and BFA, a fungal me- 
tabolite that induces disassembly’ of the Golgi stacks and impairs 
intracellular transport beyond the Golgi complex (Takatsuki and 
Tamura, 1985; Misumi et al., 1986; Oda et al., 1987; Lippincott- 
Schwartz et al., 1989; Low et al., 1991). 
Our results indicate that depolymerization of the microtubular 
network with nocodazole leads to inhibition of both axonal and 
dendritic delivery of newly synthesized viral glycoproteins. On 
the other hand, transport of the SFV and FPV glycoproteins to 
the cell surface was not impaired by BFA, although their polar- 
ized distribution was altered. 
Materials and Methods 
Hippocampal cultures. Cultures of hippocampal cells were prepared 
from the brains of 1 &d-old fetal Sprague-Dawley rats as described pre- 
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Figure 1. Effect of nocodazole on the distribution of the viral glycoproteins VSV-G and influenza HA. VSV-infected cells were fixed after 1.5 hr 
at the permissive temperature of 32°C in the absence (a. b) or presence (c, d) of 30 pM nocodazole. In the absence of nocodazole the glycoprotein 
is present exclusively in the dendrites and cell body (arrowheads in b) but not in the axons (only seen in a, arrows). Fixation of infected cells that 
had been incubated with 30 FM nocodazole resulted in the accumulation of the glycoprotein in the cell body (arrows in d). Nocodazole treatment 
also affected the delivery of the FVP HA glycoprotein to the axon. In untreated cells (e, f) the glycoprotein is present in the cell body and axons 
(arrowheads in f) but not in dendrites (arrows in e). In nocodazole-treated neurons the HA protein accumulates in the cell body (arrows in h). 
Some of the cell body labeling may represent disrupted Golgi cisternae. Scale bar, 10 km. 
viously (Banker and Cowan, 1977; Goslin and Banker, 1991). Briefly, Virus infection and immunofluorescence. Cultured hippocampal cells 
after chemical and mechanical dissociation of the hippocampi, the celis 
were plated onto polylysine-coated glass coverslips (1.5 cm diameter). 
These neurons survive for several weeks and undergo full polarization 
when cultured in serum-free medium (SFM) in the presence of a sup- 
porting layer of astrocytes (Goslin and Banker, 1991). 
were infected with VSV, SFV, or FPV as described elsewhere (Dotti et 
al., 1993) for 1 hr at 37°C with the appropriate virus (So-100 pfu/cell), 
the coverslips rinsed in SFM, and infection continued for 3-8 hr at 
37°C (FPV and WV), or for 2 hr at 39°C followed by 2 hr at 195°C 
and 1.5-6 hr at 32°C (VSV O-45 thermosensitive mutant). Intracellular 
Figure 2. Effect of BFA on the or- 
ganization of early endosomes. Hippo- 
camnal neurons were incubated with 
high activity HRP (10 mg/ml) in the 
presence of 5 kg/ml BFA for 30 min 
at 37°C. Semithick sections were cut 
parallel to the culture dish. The length 
of HRP-labeled endosomes (arrow- 
heads) in both the dendritic domain (a) 
and cell body (b) is dramatically in- 
creased (the fwo arrows in a point to 
the possible ends of a single endo- 
some). Scale bars, 1 pm. 
Figure 3. Immunofluorescence analysis of the effect of BFA on the 
distrihution of mannosidase II in cultured hippocampal neurons. Fully 
polarized cells were incubated in the absence of BFA (a, b) or in the 
presence of 10 bg/ml of BFA for 15 min (c, d). After fixation (see 
Materials and Methods) immunofluorescence labeling was performed 
using an antibody against the &/medial Golgi marker mannosidase II 
and a fluorescein-conjugated secondary antibody. Note the discrete tu- 
bular appearance of the Golgi stacks close to a nuclear pole in control 
cells (b), whereas in the BFA-treated neurons the labeling is intense 
throughout the entire cell body and the initial segment of the neurites 
(arrowhead in d). Scale bar, 10 km. 
detection of the viral glycoproteins was performed as previously de- 
scribed (Dotti and Simons, 1990). Surface appearance was done by 
incubating living infected cells with the appro$ate antibodies (see he- 
low) at 4°C for 30 min, then rinsing and fixinn. Immunofluorescence 
analysis and photography were performed wi& an Axiophot (Zeiss, 
Germany) microscope. 
Antibodies. The following primary antibodies were used: rabbit anti- 
VSV glycoprotein (Matlin et al., 1982), rabbit anti-FPV HA (Matlin et 
al., 1981), mouse monoclonal (9AB4) anti-SFV glycoprotein (Burke et 
al., 1983), rabbit polyclonal anti-mannosidase II (Moremen and Touster. 
1985), and rabbit peptide serum anti-P-COP (Pepperkok et al., 1993). 
Species-specific secondary antibodies were from Dianova GmbH (Ger- 
many). 
Microtubule depolymerization. The microtubules were depolymerized 
in cells infected with the VSV O-45 thermosensitive mutant dy adding 
30 mM nocodazole (Aldrich Chemical Co.. Milwaukee. WI) to the cul- 
ture dishes during the last 90 min at 19.5”C. The coverslips were next 
transferred for 15 min to dishes containing ice-cold buffer and 30 FM 
nocodazole and, finally, to dishes containing warm (31°C) SFM and 30 
~,LM nocodazole for 1.5-6 hr. In FPV-infected cells, the 15 min cold- 
nocodazole treatment was performed immediately after viral absorption. 
Nocodazole was maintained in the culture medium (37°C) during the 
following 9 hr of incubation. 
BFA treatment and immunojfuorescence. BFA (Sigma, St. Louis, 
MO) was prepared as a stock solution of 5 mg/ml in methanol and 
stored at -20°C. Neurons infected with either SFV or FPV were treated 
with 10 bg/ml at 3 hr postinfection. The drug was maintained in the 
culture medium for the subsequent 2 hr. The infected-treated cells were 
then incubated for the last 30 min of infection with the corresponding 
primary antibodies for the surface detection of the viral glycoproteins, 
and immunofluorescence microscopy performed as described above. 
Metabolic labeling. Neurons (14 d cultures) plated onto coverslips 
(2000 cells/coverslip on average) were infected for 1 hr with SFV and 
rinsed briefly at 37°C in IIank’s balanced salt solution (HBSS), and 
viral expression let to proceed for 3 hr in SFM. At this time, the cells 
were first washed briefly in HBSS and incubated for 30 min at 37°C in 
methionine-free SFM. Labeling was for 30 min with YS-methionine (1 
mCi/ml) in HBSS (metabolic pulse). After the metabolic pulse, the cov- 
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erslips were rinsed in HBSS, and infection continued for 2.5 hr (met- 
abolic chase). BFA (10 pg/ml) was added (1) at the beginning of the 
infection, (2j 15 min before the metabolic labeling, and (3) at the end 
of the metabolic labeling. BFA was then maintained in the chase me- 
dium until the end of thk experiments, even during the biotinylation at 
4°C (see below). The viral glycoprotein that reached the neuronal plas- 
ma membrane was detected by surface biotinylation. 
Cell surjke biotinylution. Selective biotinylation of plasma mem- 
brane proteins was carried out essentially as described (Pimplikar and 
Huttner, 1992). Tissue culture dishes containing SFV-infected, ?S-me- 
thionine-labeled cells, treated or not with BFA, were rinsed twice in 
cold Ca2+/Mg*+-PBS (1 mM CaCl, and 0.5 mu MgCl, in PBS), and 
biotinylation performed by incubating for 30 min at 4°C in Ca/Mg-PBS 
containing 1 mg/ml S-NHS-SS-biotin. As a negative control, six cov- 
erslips of SFV-infected/BFA-untreated cells were processed in the same 
way except that biotin was omitted. Biotinylation was ended by washing 
the cells in cold PBS followed by an incubation for 10 min at 4°C in 
Ca/Mg-PBS containing 0.1 M glycine and 0.3% BSA. The cells were 
then solubilized in PBS containing 2% Nonidet P-40, 0.2% SDS, and 
1 mM phenylmethylsulfonyl fluoride (PMSF). The lysates were centri- 
fuged for 10 min to remove insoluble material and then used for im- 
m;noprecipitation. 
Immunoorecioitution. SFV glycoprotein was immunoprecipitated for 
3 hr at rodm tehperature from cell lysates (I ml) with the monoclonal 
antibody 9AB4 (ascites fluid, diluted l:lOO), which recognizes the p62 
and E2 glycoproteins of SFV (Burke et al., 1983). The cell lysate was 
then incubated with 50 ~1 of 50% (v/v) protein A sepharose CL-4B 
(Pharmacia, Sweden) in distilled water. After 1 hr, the unbound material 
was removed by centrifugation, and the beads washed three times with 
NET buffer (200 mu NaCl, 1% NP-40, 2 mM EDTA, and 50 mu Tris- 
HCl, pH 7.5). The bound material was eluted with SDS-PAGE sample 
buffer (Laemmli, 1970) devoid of P-mercaptoethanol, and then diluted 
with 1 ml of lysis buffer (250 mM NaCl, 5 mM EDTA, 1% Triton X-100, 
1% BSA, 25 mM Tris-HCl pH 7.5, and 0.5 mM PMSF). After removing 
the protein A sepharose by centrifugation, the supernatant was incu- 
bated with 35 ~1 of slurry (1:1) of streptavidin-agarose (Pierce, Rock- 
ford, IL) overnight at 4°C. The unbound material was then removed by 
centrifugation and the resin washed twice with PBS/l% Nonidet P-40, 
and twice with PBS/O.1 % Nonidet P-40, 0.5 M NaCl. Bound protein 
was eluted by boiling with SDS-PAGE sample buffer and analyzed by 
SDS-PAGE (Laemmli, 1970) followed by fluorography. The densito- 
metric analysis of the autoradiograms was performed with the program 
NIH-IMAGE (VerSiOll 1.40). 
Electron microscopy. Analysis of the endocytic pathway was per- 
formed as described in early work (Parton et al., 1992). Briefly, the 
cells were rinsed in HBSS and incubated in neuronal medium contain- 
ing high-activity horseradish peroxidase (HRP; Serva Biochemicals, 
Heidelberg, Germany) at a concentration of 10 mg/ml for 30 min at 
37°C in the presence of brefeldin A (10 kg/ml). At the end of the 
incubation the cells were rinsed and fixed in 0.1% glutaraldehyde in 
100 mu cacodylate buffer. After embedding in Epon, semithick sections 
(200 nm) were prepared and analyzed at an accelerating voltage of 60 
kV. 
For the ultrastructural analysis of the Golgi apparatus untreated rat 
hippocampal neurons or neurons treated for 30 min with 10 kg/ml BFA 
were stained for thiamine pyrophosphatase (TPPase) as described by 
Griffiths et al. (1983). After Epon embedding, sections were cut paralIe1 
to the substratum and were viewed without further contrasting. 
Protein secretion analysis. Hippocampal neurons grown on 3 cm tis- 
sue culture plastic dishes (150,000 cells/dish) were washed twice with 
HBSS and then incubated for 30 min at 37°C with methionine-free 
SFM. The cells were then labeled with 35S-methionine (1 mCilm1) as 
described above (metabolic pulse), washed, and incubated for various 
times in 1 ml of medium containing excess cold methionine (metabolic 
chase). BFA (5-10 mg/ml) was included in the pulse and chase media. 
At the times indicatelin Figure 8, aliquots of medium were taken and 
urecinitated in 10% trichloroacetic acid, and radioactivity measured in 
I  
a sci;ltillation counter 
Results 
Nocodazole blocks transport of newly synthesized viral 
glycoproteins 
The effect of microtubule depolymerization on dendritic deliv- 
ery of viral glycoproteins was first studied in hippocampal neu- 
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Figure 5. Effect of BFA on the distribution of B-COP. a and b, and e and f  are low and high magnification, respectively, of untreated cultured 
hippocampal neurons stained with a anti-B-COP antibody. Note that the labeling is restricted in all cells to one pole of the cell body. After treatment 
with 10 pg/ml of BFA for 15 min (c and d, low magnification, and g and h, high magnification) the staining is diffuse throughout the entire cell 
body and also extends into some of the neurites. 
rons that were infected with the VSV O-4.5 thermosensitive mu- 
tant and incubated in the presence or absence of nocodazole. For 
this strain, synchrony of delivery of newly synthesized viral gly- 
coproteins from the rough endoplasmic reticulum to the plasma 
membrane can be achieved by successive temperature shifts 
(Bergmann et al., 1981; Bergmann and Singer, 1983; Griffiths 
et al., 1985). At 39°C the WV glycoprotein accumulates in the 
rough endoplasmic reticulum, while it moves to the Golgi com- 
plex at 20°C and only at 32°C does occur detectable transport 
to the plasma membrane. As shown previously (Dotti and Si- 
mons, 1990), the VSV glycoprotein is selectively transported to 
the somatodendritic territory of infected hippocampal cells. 
Immunofluorescence analysis using specific antibodies 
showed that microtubule depolymerization (see Materials and 
Methods) during incubations of infected cells either at 20°C or 
at 32°C resulted in suppression of dendritic delivery of the VSV 
glycoprotein (Fig. la-c). As determined by counting labeled 
neurons (about 150 of each condition) in representative fields of 
infected cells, in 71% of them dendritic transport of the VSV 
glycoprotein was abolished by the nocodazole treatment. Ap- 
proximately the same degree of inhibition was observed when 
incubation with nocodazole at 32°C was extended for 6 hr. Since 
t 
these cells are highly sensitive to nocodazole (Dotti and Banker, 
1991), a likely explanation for the remaining 30% of cells in 
which dendritic labeling was observed might be that the protein 
had already been transported to the surface before the drug was 
added. In all cells in which dendritic transport of the VSV gly- 
coprotein was absent, a more intense labeling was seen in the 
cell body, as compared to untreated cells. 
The effect of nocodazole was next studied in hippocampal 
cells infected for 9 hr with FPV. In untreated cells, the FPV HA 
is delivered to the axons within this time (Dotti and Simons, 
1990). However, immunofluorescence detection of the FPV HA 
in infected cells incubated with nocodazole showed that micro- 
tubule depolymerization had a dramatic effect on the axonal 
transport of the HA glycoprotein, which was completely abol- 
ished and the HA-specific labeling restricted to the cell body 
(Fig. Id-f). 
In both cases the effect of nocodazole was reversible, since 
washing out the drug and continuing infections with the VSV 
O-45 mutant or FPV for various times resulted in progressive 
reappearance of the corresponding viral glycoproteins in the 
dendritic or axonal territories, respectively (data not shown). In 
addition, plaque titration assays showed that formation of infec- 
Figure 4. Staining of TPPase in control and BFA-treated cells. Untreated rat hippocampal neurons (a, b) or neurons treated for 30 min with BFA 
(c, d) were fixed and stained for TPPase. In control cells (a, b) staining is evident in the cell body within a single cisterna of the Golgi complex 
(small arrowheads) as shown at low magnification in a and at higher magnification in b. No staining is evident within the nuclear envelope (large 
arrowheads). After BFA treatment (c, d) staining is evident within tubular profiles, characteristic of cisternae of the endoplasmic reticulum, which 
extend into the cell periphery. The nuclear envelope (large arrowheads) is also labeled as shown at higher magnification in d. No stacked Golgi 
cisternae were observed under these conditions. N, nucleus. Scale bars: a and c, 1 ym; b and d, 200 nm. 
4264 Cid-Arregui et al. * Nocodazole and Brefeldin A in Viral Protein Transport and Sorting 
tive VSV was not affected by nocodazole (data not shown), 
suggesting that efficient viral budding was taking place from the 
cell body. Collectively, these results indicate that, as shown pre- 
viously for other cell types (Rogalski et al., 1984), the inhibitory 
effect of nocodazole on viral glycoprotein delivery is due to an 
overall reduction of protein transport to the processes corre- 
sponding to the dispersal of the Golgi apparatus rather than to 
a complete disruption of the exocytic pathway. 
BFA affects the intracellular organization qf cultured 
hippocampal neurons 
Previous studies using a number of cell types, such as hepato- 
cytes, rat kidney, AtT20, and HeLa cells, have shown that BFA, 
at a concentration ranging from 1 to 10 kg/ml, induces redistri- 
bution of Golgi proteins into the endoplasmic reticulum via long, 
tubulovesicular structures extending from the Golgi apparatus 
along microtubules (Fujiwara et al., 1988; Lippincott-Schwartz 
et al., 1989, 1990; Tooze and Hollinshead, 1992). Prior to ex- 
amination of the effect of BFA on viral glycoprotein transport/ 
sorting in hippocampal neurons, we determined whether BFA 
induced in these cells morphological changes in the tubular en- 
dosomes and the Golgi cisternae similar to those described pre- 
viously for established cell lines. 
The organization of the neuronal endocytic compartment after 
BFA treatment was analyzed by electron microscopy. By using 
the fluid phase marker horseradish peroxidase (HRP), we 
showed previously (Parton et al., 1992) that the neuronal early 
endosomes have a homogeneous tubulovesicular appearance. 
After incubating the cells in the presence of 10 pg/ml of BFA, 
the tubulovesicular endosomes became progressively longer and 
less vesicular, extending up to 10 pm (Fig. 2). 
The effect of BFA on the Golgi apparatus in neurons was 
demonstrated for the &/medial Golgi marker mannosidase II by 
immunofluorescence microscopy (Fig. 3). In untreated neurons 
the mannosidase II labeling is localized to the Golgi apparatus, 
which in these cells appears as a network of tubules close to a 
nuclear pole (Fig. 3a,b). After 15 min of BFA treatment, the 
staining became more diffuse and a dense punctate staining pat- 
tern appeared throughout the cell body and the initial segment 
of the dendrites (Fig. 3c,d), suggesting the disassembly of the 
Golgi apparatus. 
We next used TPPase, a marker of medialltrans-Golgi cister- 
nae (Griffiths et al. 1983) to analyze the effect of BFA on the 
organization of the Golgi apparatus. As in other cell types TPPa- 
se staining was restricted to one or two cisternae of the Golgi 
in control cells (Fig. 4a,b). In BFA-treated cells stacked Golgi 
cisternae were no longer observed and the TPPase staining was 
observed within the endoplasmic reticulum that surrounds the 
nucleus and extends into the cell periphery (Fig. 4c,d). Some 
groups of tubular/vesicular elements also showed weak TPPase 
reactivity after BFA treatment (results not shown). Whether 
these represented Golgi remnants as described by Hidalgo et al. 
(1992), elements of the TGN, or both is not clear. However, we 
can conclude from these experiments that the stacked Golgi cis- 
ternal organization is disrupted upon BFA treatment and that, as 
in other cells, there must be fusion of Golgi elements with the 
ER. 
Consistent with the change of Golgi organization, BFA treat- 
ment also changed the distribution of B-COP, a molecule in- 
volved in the transport of membrane proteins from the endo- 
plasmic reticulum to the Golgi apparatus (Pepperkok et al., 
1993). In untreated cells the B-COP staining was clustered to 
one pole of the cell body (Fig. 5a,b; e,f>, agreeing with the 
localization of the rough endoplasmic reticulum and Golgi ap- 
paratus of these cells (J. Krijnse-Locker, R. G. Parton, G. Grif- 
fiths, S. Fuller, and C. Dotti, unpublished observations). How- 
ever, after 15 min of BFA treatment the staining appeared more 
diffuse in the cell body and was also evident in the proximal 
segment of the processes (Fig. 5c,d; g,h). 
BFA does not block transport of viral glycoproteins to the 
plasma membrane but gffects their normal distribution 
The effect of BFA on protein transport and sorting in neurons 
was first studied by immunofluorescence microscopic analysis 
of SFV and FPV glycoprotein expression. The intracellular and 
surface-located glycoproteins were separately detected by using 
different fixation methods including or not permeabilization, re- 
spectively (see Materials and Methods). At short times after in- 
fection (l-3 hr) the SFV glycoprotein was found intracellularly, 
mainly restricted to the cell body (data not shown). However, at 
5 hr postinfection the SFV glycoprotein was present on the cell 
body and dendritic surfaces (Fig. 6b). Addition of BFA at the 
third hour postinfection and further incubation for 2 hr more did 
not reveal any change in the surface distribution of the SFV 
glycoproteins, although the intensity of labeling was somewhat 
lower than in control untreated cells. Besides labeling on the 
dendritic surface, however, in 3040% of the BFA-treated cells 
a punctate staining was also observed on processes with clear 
axonal characteristics (Fig. 6d). 
As observed for the SFV glycoprotein, transport of the FPV 
HA glycoprotein to the plasma membrane was not blocked by 
BFA treatment, yet the normal surface distribution of the protein 
was altered. In untreated neurons, the HA glycoprotein was 
found in the cell body and axonal membrane (Fig. 7b). In BFA- 
treated neurons, the HA-specific labeling was not only seen as- 
sociated with the axonal surface but also on the dendritic surface 
(Fig. 7d). 
The overall effect of BFA on protein transport was further 
determined by measuring total protein secretion. Neurons cul- 
tured on dishes were metabolically labeled for 30 min in the 
presence of 5 pg or 10 pg/ml of BFA and, in the continuous 
presence of the drug, the radioactivity released to the medium 
was measured at different times postlabeling. As shown in Fig- 
ure 8, protein secretion was only partially inhibited (20%) by 
BFA, irrespective of the concentration of BFA used. 
The intracellular processing of SFV glycoproteins is altered by 
BFA 
The above results suggested that sorting but not transport of 
newly synthesized viral glycoproteins is sensitive to BFA. Since 
BFA induces profound changes in the organization of the Golgi 
apparatus and the endoplasmic reticulum, we analyzed whether 
this drug may alter the normal processing of newly synthesized 
SFV glycoproteins. 
All the structural proteins of SFV are synthesized as a poly- 
protein whose major component, ~62, is the precursor form of 
the E2 and E3 glycoproteins. The p62 protein undergoes exten- 
sive posttranslational modifications. During chain elongation in 
the endoplasmic reticulum high mannose oligosaccharides are 
added that, in the different stacks of the Golgi apparatus, are 
trimmed and further modified to form complex glycoproteins 
containing N-acetylglucosamine, galactose, sialic acid, and fu- 
case. Either in the TGN or during transport to the plasma mem- 
brane, the p62 protein is cleaved to yield E2 and E3 (de Curtis 
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Figure 6. Effect of BFA on the den- 
dritic distribution of the SFV-glycopro- 
tein. A and B, Untreated cells. Incuba- 
tion of infected cells with the 9AB4 an- 
tibody at 4°C before fixation and im- 
munofluorescence microscopy shows 
the viral glycoprotein in the cell body 
and the dendrites (urrowheacis in B). 
Processes with axonal appearance are 
unlabeled (arrow in B). C and D, BFA- 
treated cells. Incubation with 10 kg/ml 
of BFA in the last 2 hr of infection re- 
sults in a similar pattern: dendritic la- 
beling in the form of dispersed clusters 
on the dendrites (arrowheads in D). 
Some axonal labeling is also evident 
(arrow). The nature of the processes as 
axons and dendrites, thin and of uni- 
form diameter and tapering with dis- 
tance from the cell body, respectively, 
is unequivocal from the corresponding 
phase contrast photographs (A, C). 
Scale bar, 10 urn. 
and Simons, 1988). Once in the plasma membrane the cytoplas- 
mic domains of El, E2, and E3 are recruited by the nucleocapsid 
and budding of a mature virus is initiated. 
Hippocampal neurons were infected with SFV for 2 hr and 
the newly synthesized viral glycoproteins labeled with ‘S-me- 
thionine. Either at the time of infection or just before addition 
of the radioactive precursor BFA was added to the medium at 
10 pg/ml. The presence of labeled viral glycoproteins at the 
neuronal surface was determined 2.5 hr later by surface bioti- 
nylation at 4°C followed by immunoprecipitation, recovery of 
the biotinylated immunoprecipitates with streptavidin-agarose, 
SDS-PAGE, and fluorography. The antibody used for the im- 
munoprecipitation (mAb 9AB4) recognizes both the p62 and the 
E2 glycoproteins (Burke et al., 1983). As shown in Figure 9, in 
infected non-BFA-treated cells only the E2 glycoprotein reached 
the plasma membrane (lane 1 b), indicating that efficient cleav- 
age of p62 takes place before or during transport to the plasma 
membrane. In contrast, in SFV-infected cells, treated with BFA 
either 15 min before the metabolic pulse (lane 2b) or from the 
beginning of infection (lane 3b), both p62 and E2 were evident 
Figure 7. BFA induces redistribution 
of the FPV HA glycoprotein to the den- 
drites of infected hippocampal neurons. 
A and B, Untreated cells. The HA gly- 
coprotein is observed on the surface of 
the cell body and one process of fixed, 
unpermeabilized cells. It ended in a 
noninfected cell. The thick processes 
(nrrowhmds) are the cell’s dendrites 
and appear devoid of labeling except at 
sites of axonal contacts, probably from 
other infected cells. C and D, BFA- 
treated neurons. Addition of 10 ug/ml 
of BFA during the last 3 hr of infection 
induces appearance of HA labeling on 
the dendritic surface (arrowheads). Ax- 
onal labeling persists (arrows). Scale 
bar, 10 km. 
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Figure 8. Effect of BFA on total protein secretion. Hippocampal cells 
were pulse-labeled with YS-methionine in 1 ml of neuronal medium for 
30 min. The cells were then washed in medium containing excess cold 
methionine and chased for 30 min, 2 hr, and 4 hr in the presence of 5 
kg/ml or 10 pg/ml of BFA. Aliquots were taken at the end of the pulse 
and at different chase intervals, proteins precipitated with trichloroacetic 
acid (lo%), and radioactivity counted. The average data from two ex- 
periments is shown. A reduction of 20% in the amount of radioactive 
protein occurred at both BFA concentrations. 
on the plasma membrane. Densitometric tracings of the autora- 
diographic bands of representative blots like that of Figure 9 
revealed that BFA induced a reduction of 20% (when BFA was 
added 15 min before the pulse) and 35% (BFA added at the time 
of infection) in the total amount of viral protein on the plasma 
membrane. In addition, the BFA treatment changed the relative 
amount of p62 that reached the plasma membrane, from less 
than 5% of the total biotinylated protein in untreated cells (lane 
lb) to nearly 60% in BFA-treated cells (lane 2b). Finally, in 
BFA-treated cells the E2 glycoprotein appeared of lower molec- 
ular weight than in untreated cells, probably as a result of de- 
fective glycosylation. 
A 
B 
Figure 9. Fluorography of streptavi- 
din-agarose precipitated biotinylated 
SFV E2 glyeoprotein. Lanes I, control 
untreated neurons. In lanes 2, BFA (10 
p,g/ml) was added at the time of infec- 
tion and maintained throughout the en- 
tire experiment. In lanes 3, BFA was 
added 15 min before metabolic label- 
ing. Lanes a, total immunoprecipitated 
material; lanes b, eluates of the strep- 
tavidin-agarose precipitation. In control 
cells only the E2 viral protein is present 
on the plasma membrane. In BFA- 
treated neurons ~62 is also detected. 
The arrows point to the E2 glycopro- 
tein and to ~62. Note the slight shift in 
E2 molecular weight in the BFA-treat- 
ed cells. 
1 
2 
3 
These results demonstrate that BFA is able to change the in- 
tracellular processing of the glycoproteins (shift in E2 molecular 
weight and presence of p62 on the membrane), but not to abolish 
their transport to the plasma membrane. 
Discussion 
BFA has been widely used to dissect the machinery involved in 
several steps of intracellular traffic (Lippincott-Schwartz et al., 
1991). Different cell types react in a different manner to the 
drug. In most cases, BFA disassembles the Golgi stacks and this 
perturbs membrane traffic and leads to protein accumulation in 
the endoplasmic reticulum (Armstrong and Warren, 1990; Klaus- 
ner et al., 1992). There are, however, some exceptions to this 
effect of BFA. In kangaroo rat (PtK,) cells the Golgi complex 
is resistant to the drug at concentrations that normally have a 
dramatic effect in other cell types (Kistakis et al., 1991). In 
MDCK epithelial cells, depending on the concentration of BFA 
used, the TGN is unaffected or completely disassembled (Hun- 
ziker et al., 1991; Low et al., 1991; Wagner et al., 1994). In 
hypothalamic neurons, large concentrations of intracerebrally in- 
jected BFA perturb the structure of the Golgi complex but do 
not affect the secretion of vasopressin and oxytocin (Pow and 
Morris, 1992). 
In addition, BFA treatment has been shown to affect protein 
sorting in MDCK cells (Low et al., 1991, 1992). Apical delivery 
of secretory proteins and dipeptidyl peptidase IV, a transmem- 
brane apical protein, is impaired by the drug. This decrease in 
apical exocytosis leads to enhanced basolateral secretion and to 
increased delivery of dipeptidyl peptidase to the basolateral me- 
dium. Matter et al. (1993) showed that BFA affects the sorting 
in the TGN to both the basolateral and apical surfaces, although 
transport to the plasma membrane still occurs (Matter et al., 
1993). Missorting without an effect on protein transport has also 
1 2 3 
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been found for the transcytosis of mutated LDL receptors and 
for the exocytosis of the HA glycoprotein in MDCK cells (Mat- 
ter et al., 1993; Wagner et al., 1994). 
In the present study we examined the effects of BFA in a 
model system, the rat hippocampal neuron culture, and found 
that transport to the plasma membrane of newly synthesized HA 
and E2 viral glycoproteins takes place normally, although their 
polarized distribution is changed by BFA. 
Our data leave little doubt that the viral glycoproteins had 
reached the plasma membrane despite the fact that BFA disas- 
sembled the Golgi stacks and induced the dissociation of B-COP 
The appearance of the viral glycoproteins in the plasma mem- 
brane was demonstrated by immunofluorescence microscopy of 
fixed nonpermeabilized neurons and by surface biotinylation. By 
the latter means we detected in the plasma membrane of SFV- 
infected/BFA-treated cells not only the E2 glycoprotein but also 
its precursor, ~62. Moreover, the E2 glycoprotein displayed a 
molecular weight slightly lower than normal. This could result 
from incomplete glycosylation due to the BFA effects on the 
organization of the Golgi apparatus. Such change in molecular 
size, however, does not seem to be caused by a failure in sialic 
acid addition, because neuraminidase treatment of biotinylated 
E2 from BFA-treated and untreated cells changed its electro- 
phoretic mobility in a similar manner (data not shown). On the 
other hand, the appearance of p62 in the plasma membrane is a 
very characteristic feature induced by BFA. Since the cleavage 
of p62 into E2 normally takes place in the TGN and during 
transport to the plasma membrane, the presence of p62 in the 
surface might result from a shift in distribution of the responsible 
proteases, that is, from the Golgi apparatus to the plasma mem- 
brane, induced by BFA. Alternatively, BFA might be altering 
the optimal conditions for cleavage in the exocytic vesicles, for 
example, by modifying their pH. The formal possibility also 
exists that some of the p-62 and E2 present in the plasma mem- 
brane of the BFA-treated neurons might result from direct trans- 
port from the rough endoplasmic reticulum. 
Altogether, these results show that although BFA alters three 
important functions of the TGN (sorting, glycosylation, and pro- 
teolytic cleavage), the secretory pathway remains functional and 
transport to the plasma membrane is still possible. 
What are the molecular targets of BFA? In non-neuronal cells 
BFA treatment inhibits nucleotide exchange in ARF proteins 
(Donaldson et al., 1991a,b), small GTP-binding proteins in- 
volved in regulating coat assembly in the Golgi complex during 
intra-Golgi transport (Stearns et al., 1990; Serafini et al., 1991). 
Due to this inhibition, B-COP and other coat components cannot 
associate with the Golgi membranes, leading to the disassembly 
of the Golgi apparatus (Robinson and Kreis, 1992). BFA treat- 
ment has also been shown to induce release of y-adaptin and 
clathrin from the TGN (Wagner et al., 1994). Therefore, BFA 
may have altered protein sorting in the neurons by a mechanism 
similar to that operating in non-neuronal cells. The effect of BFA 
on protein sorting may also involve trimeric GTP-binding pro- 
teins. For example, AIF,, which activates trimeric G proteins, 
inhibits the release of y-adaptin by BFA treatment (Wagner et 
al., 1994). Apical and basolateral sorting in perforated epithelial 
cells (Pimplikar and Simons, 1993) as well as transcytosis (Bom- 
se1 and Mostov, 1992) also seem to be under control of these 
proteins. 
The data obtained with BFA on protein sorting in hippocam- 
pal neurons further confirm the involvement of different sets of 
BFA targets for protein sorting and transport in the Golgi ap- 
paratus and, in view of the similar effects in different polarized 
cells, strengthen the idea that the sorting and transport machin- 
ery is conserved among different cell types. The elucidation of 
the specific components have to be explained in molecular terms 
by future work. 
The similarities in the membrane sorting pathway do not ex- 
tend to the role of microtubules in MDCK cells and neurons. In 
MDCK cells, the minus ends of the microtubules are mainly 
underneath the apical membrane while the plus ends are toward 
the basal membrane (Bacallao et al., 1989). Apically, there are 
also microtubules running parallel to the surface with mixed 
polarity. In the hippocampal neurons the axonal microtubules 
are uniformly oriented with their plus ends distal to the cell 
body. The microtubules in the dendrites close to the cell body 
are of mixed polarity while the microtubule extending into the 
distal regions of the dendrites are of uniform polarity with their 
plus ends distally like in the axons (Baas et al., 1988). From 
previous work it is well known that microtubules play a role in 
the delivery of axonal proteins from the Golgi complex to the 
axonal surface (Hammerschlag and Brady, 1988). Newly syn- 
thesized axonal proteins use kinesin as a motor to move distally 
(Brady et al., 1990; Hirokawa et al., 1991). Transport of the 
influenza HA was blocked in the cell body as expected by treat- 
ing the hippocampal cultures with nocodazole. Also, transport 
of apical proteins in MDCK cells from the TGN to the apical 
side is facilitated by microtubules (Rindler et al., 1987). The 
microtubular motor employed in MDCK cells has not yet been 
identified but in contrast to axons, the movement is toward the 
minus ends. In MDCK cells the basolateral transport of the VSV 
glycoprotein from the TGN is not affected by depolymerization 
of the microtubules (Salas et al., 1986). However, we show here 
that dendritic transport from the Golgi complex is clearly inhib- 
ited by nocodazole treatment of the neurons. Most likely, the 
viral glycoproteins remain in the cell body because the axonal 
and the dendritic carrier vesicles require microtubules for move- 
ment out into the neurites. We assume, in analogy with MDCK 
cells, that sorting into carriers occurs in the absence of micro- 
tubules and that microtubules are involved in providing tracks 
for moving vesicles to their final destination. It has been pro- 
posed that dendritic carrier vesicles would use microtubules hav- 
ing their plus ends in the cell body to differentiate them from 
axonal microtubules. However, these tracks would not carry the 
vesicles all along the way toward the distal part of the dendrites. 
Therefore, it would be possible that the microtubule tracks are 
marked by specific proteins (e.g., MAP2, dendritic) and that the 
putative carrier vesicles carry tags that position them on the right 
tracks. Alternatively, plus end-directed motor proteins different 
from the kinesin family (Gho et al., 1992) could determine the 
correct pathway of the exocytic vesicles. 
The sorting and targeting of cell surface proteins in neurons 
is a fascinating subject that has now become accessible to ex- 
perimental analysis. It is encouraging that strategies that have 
been useful in dissecting epithelial polarity are proving their 
worth once again. The future challenge will be to describe in 
molecular terms the mechanisms responsible for generating and 
maintaining cell polarity of both neurons and epithelial cells. 
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